INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| 47.38 billion by 2029 | at a CAGR of 14.9% | North America |
| by Process | by Drug Type | by Therapeutic Area |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Drug Discovery Services Market Overview
The global drug discovery services market was valued at 17.92 billion in 2022 and is projected to reach 47.38 billion by 2029, growing at a CAGR of 14.9% from 2022 to 2029.
To meet the different unmet medical demands, new medications are constantly needed. There is still no cure for a number of illnesses, including cardiovascular, cancer, uncommon genetic, and neurological diseases. The demand for new medications is skyrocketing as new ailments emerge. The increased development and discovery of innovative medications are predicted to lead to a multifold increase in the need for drug discovery services. It takes a lot of effort and time to develop new drugs. The need for specialized knowledge across several scientific areas grows as the process of discovering new drugs becomes more complex. Toxicology, medicinal chemistry, pharmacology, and formulation development experts are typically involved in the search for new medications. Research organizations and pharmaceutical businesses can cut costs and time by outsourcing these services. Without making significant expenditures, the market for outsourced drug delivery services gives customers access to specialized infrastructure and knowledge.
Growing chronic diseases, the use of artificial intelligence in drug discovery, and the development of pharmaceuticals and biologics are all predicted to have an impact on the market for drug discovery services. Diseases including cancer, diabetes, and cardiovascular disease are becoming more common. Increased spending on R&D and the need for clinical trials in the biopharmaceutical sector have an impact on market expansion. The expansion of the drug discovery services market is anticipated to be fueled by the demand for novel therapies in a number of therapeutic areas.
Also, pharmaceutical and biopharmaceutical firms are increasingly opting for fully integrated or functional outsourcing services for drug discovery and development, from the early research stage through the late-stage development phase, as a result of rising R&D spending by those industries. Due to the financial constraints facing pharmaceutical businesses and the need to control fixed costs, outsourcing has emerged as a tactical solution to the lack of internal resources needed for new product development. The biggest pharmaceutical corporations are changing to a leaner, highly outsourced corporate model.
| ATTRIBUTE | DETAILS |
| Study period | 2022-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion) |
| Segmentation | By Process, Drug Type, Therapeutic Area, and Region. |
| By Process
 |
|
| By Drug Type
 |
|
| By Therapeutic Area
 |
|
| By Region
 |
|
Drug Discovery Services Market Segment Analysis:
Based on process, drug type, therapeutic area, and region, the global market for drug discovery services is divided into these categories.
On the basis of the process drug discovery services are subdivided into Target Selection and Hit-to-lead. A complex interplay of scientific, medical, and strategic factors affects target selection in drug development, which is defined here as the choice to concentrate on identifying an agent with a specific biological function that is anticipated to have therapeutic utility. Target selection also takes into account context. Stakeholders (investors), customers (patients/doctors), and other modifying elements, such as legal and political factors (possible payers), need to be balanced appropriately. Hit to lead (H2L), also known as lead generation, is a phase of early drug development in which small molecule hits from a high throughput screen (HTS) are assessed and subjected to restricted optimization to identify prospective lead compounds. Lead optimization (LO), a second stage of drug discovery, involves a more thorough optimization of these lead molecules. The following path, which includes a hit-to-lead stage, characterizes the typical drug discovery process. The hits also go through a restricted optimization process to increase metabolic half-life so that the drugs can be evaluated in disease-simulating animals, as well as to increase selectivity against binding to other biological targets that can have unfavorable side effects.
Small M and Biologics are the drug types of the drug discovery services market. Due to the simplicity of working with small molecules, their low cost, and the rising number of start-ups and new entrants concentrating on creating small-molecule medications, this market has a sizable share. While, Biologics are huge molecules with complicated, heterogeneous structures that are frequently unstable and sensitive to environmental factors, in contrast to small molecule medications that are chemically synthesized and have a known structure.
Also, drug discovery services are further divided into Oncology, Neurology, and Infectious. In 2020, the global market for drug discovery services was dominated by the oncology sector. This is mostly linked to the uptick in cancer-related medication research activity. The population’s heightened propensity for various cancers has fueled the oncology market’s expansion. The International Agency for Research on Cancer estimates that there will be a number of new cases of cancer and approximately 10 million cancer-related deaths in 2020. Numerous juvenile cancers have seen substantial advancements in their prognosis, treatment, and prevention thanks to oncology, the study of cancer and tumors. Despite these advancements, cancer continues to be the leading cause of disease-related death in children. In the field of medicine known as oncology, tumors are studied, treated, diagnosed, and prevented. An oncologist is a doctor who specializes in oncology. A doctor with training in the study, diagnosis, and treatment of neurological problems is known as a neurologist. Numerous neurologic illnesses are treated by neurologists, including stroke, seizures, Parkinson’s disease-like movement disorders, multiple sclerosis-like autoimmune neurologic disorders, migraine-related headache disorders, and dementias including Alzheimer’s disease. Neurologists may also take part in basic or translational research, clinical trials, and clinical research. In both the inpatient and outpatient settings, neurologists examine patients who have been referred to them by other medical professionals. Beginning their encounters with patients, neurologists take a thorough medical history before providing a physical examination with an emphasis on the neurological system. The patient’s cognitive function, cranial nerves, motor strength, sensibility, reflexes, coordination, and gait are all evaluated as part of the neurological examination.
Drug Discovery Services Market Players:
The major players operating in the global Drug Discovery Services industry include the major market players are Eurofins Scientific SE, Evotec SE, WuXi AppTec, Syngene International Limited, Curia Global Inc., Pharmaron Beijing Co., Ltd., Piramal Enterprises Limited, Thermo Fisher Scientific Inc., Jubilant Pharmova Limited, GenScript Biotech Corporation, Oncodesign Services, and Selvita S.A.
Recent Development:
23 March 2023: Curia collaborated with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.
9 June 2022: Curia and Replicate Bioscience collaborated to create a groundbreaking development platform for self-replicating RNA (siRNA).
Who Should Buy? Or Key stakeholders
- Manufacturing
- End-Use Industries
- BFSI
- Automotive
- Manufacturing & Construction
- Regulatory Authorities
- Research Organizations
- Information Technology
- Materials & Chemicals
Drug Discovery Services Market Regional Analysis:
Geographically, the drug discovery services market is segmented into North America, South America, Europe, APAC, and MEA.
- North America: includes the US, Canada, Mexico
- Europe: includes the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and the Rest of APAC
- South America: includes Brazil, Argentina, and the Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and the Rest of MEA
The largest geographic market for drug discovery services is predicted to be in North America in 2022, with Europe coming in second. The market is expanding due to the region’s well-established pharmaceutical sector, ongoing R&D research, high R&D investment, expansion in the biosimilars and generics markets, and an increase in the outsourcing of R&D services by pharmaceutical and biopharmaceutical businesses. The largest pharmaceutical market in the world is North America, which is also home to many of the largest global pharmaceutical and biopharmaceutical companies. Spending on pharmaceutical research and development in North America is among the highest in the world. In 2022, the area held a sizable 34% market share. Additionally, the region is a sizable market for ready-to-use dosage forms and bulk pharmaceuticals.
In 2022, the United States held a 24.1% market share. The market in the area operates as a free economy with transparent trading practices and restrictions on anti-competitive behavior. The market for biosimilars in the United States is largely due to biologics being more expensive. As a result, one of the main competitors for biosimilars is the US market for drug discovery services.
Key Market Segments: Drug Discovery Services Market
Drug Discovery Services Market by Process, 2020-2029, (USD Billion)
- Target Selection
- Hit-to-lead
Drug Discovery Services Market by Drug Type, 2022-2029, (USD Billion)
- Small Molecule
- Biologics
Drug Discovery Services Market by Therapeutic Area, 2022-2029, (USD Billion)Â
- Oncology
- Neurology
- Infectious
Drug Discovery Services Market by Region, 2022-2029, (USD Billion)Â
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
           Important Countries in All Regions Are Covered
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered:
- what is the expected growth rate of the drug discovery services market over the next 7 years?
- who are the major players in the drug discovery services market and what is their market share?
- what are the end-user industries driving demand for the market and what is their outlook?
- what are the opportunities for growth in emerging markets such as Asia-Pacific, the middle east, and Africa?
- how is the economic environment affecting the drug discovery services market, including factors such as interest rates, inflation, and exchange rates?
- what is the expected impact of government policies and regulations on the drug discovery services market?
- what is the current and forecasted size and growth rate of the global drug discovery services market?
- what are the key drivers of growth in the drug discovery services market?
- who are the major players in the market and what is their market share?
- what are the distribution channels and supply chain dynamics in the drug discovery services market?
- what are the technological advancements and innovations in the drug discovery services market and their impact on product development and growth?
- what are the regulatory considerations and their impact on the market?
- what are the challenges faced by players in the drug discovery services market and how are they addressing these challenges?
- what are the opportunities for growth and expansion in the drug discovery services market?
- what are the services offerings and specifications of leading players in the market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL DRUG DISCOVERY SERVICES MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON THE DRUG DISCOVERY SERVICES MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL DRUG DISCOVERY SERVICES MARKET OUTLOOK
- GLOBAL DRUG DISCOVERY SERVICES MARKET BY PROCESS, 2020-2029, (USD BILLION)
- TARGET SELECTION
- HIT-TO-LEAD
- GLOBAL DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE, 2020-2029, (USD BILLION)
- SMALL MOLECULE
- BIOLOGICS
- GLOBAL DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA, 2020-2029, (USD BILLION)
- ONCOLOGY
- NEUROLOGY
- INFECTIOUS
- GLOBAL DRUG DISCOVERY SERVICES MARKET BY REGION, 2020-2029, (USD BILLION)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- EUROFINS SCIENTIFIC SE
- EVOTEC SE
- WUXI APPTEC
- SYNGENE INTERNATIONAL LIMITED
- CURIA GLOBAL INC.
- PHARMARON BEIJING CO., LTD.
- PIRAMAL ENTERPRISES LIMITED
- THERMO FISHER SCIENTIFIC INC.
- JUBILANT PHARMOVA LIMITED
- GENSCRIPT BIOTECH CORPORATION
- ONCODESIGN SERVICES
- SELVITA S.A.
                                   *THE COMPANY LIST IS INDICATIVE
 LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY REGION (USD BILLION) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â NORTH AMERICA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â NORTH AMERICA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â NORTH AMERICA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â NORTH AMERICA DRUG DISCOVERY SERVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â US DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 10Â Â Â Â Â Â US DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 11Â Â Â Â Â Â US DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 12Â Â Â Â Â Â CANADA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 13Â Â Â Â Â Â CANADA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 14Â Â Â Â Â Â CANADA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 15Â Â Â Â Â Â MEXICO DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 16Â Â Â Â Â Â MEXICO DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 17Â Â Â Â Â Â MEXICO DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 18Â Â Â Â Â Â SOUTH AMERICA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 19Â Â Â Â Â Â SOUTH AMERICA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 20Â Â Â Â Â Â SOUTH AMERICA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 21Â Â Â Â Â Â SOUTH AMERICA DRUG DISCOVERY SERVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 22Â Â Â Â Â Â BRAZIL DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 23Â Â Â Â Â Â BRAZIL DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 24Â Â Â Â Â Â BRAZIL DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 25Â Â Â Â Â Â ARGENTINA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 26Â Â Â Â Â Â ARGENTINA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 27Â Â Â Â Â Â ARGENTINA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 28Â Â Â Â Â Â COLOMBIA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 29Â Â Â Â Â Â COLOMBIA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 30Â Â Â Â Â Â COLOMBIA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 31Â Â Â Â Â Â REST OF SOUTH AMERICA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 32Â Â Â Â Â Â REST OF SOUTH AMERICA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 33Â Â Â Â Â Â REST OF SOUTH AMERICA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 34Â Â Â Â Â Â ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 35Â Â Â Â Â Â ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 36Â Â Â Â Â Â ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 37Â Â Â Â Â Â ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 38Â Â Â Â Â Â INDIA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 39Â Â Â Â Â Â INDIA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 40Â Â Â Â Â Â INDIA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 41Â Â Â Â Â Â CHINA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 42Â Â Â Â Â Â CHINA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 43Â Â Â Â Â Â CHINA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 44Â Â Â Â Â Â JAPAN DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 45Â Â Â Â Â Â JAPAN DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 46Â Â Â Â Â Â JAPAN DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 47Â Â Â Â Â Â SOUTH KOREA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 48Â Â Â Â Â Â SOUTH KOREA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 49Â Â Â Â Â Â SOUTH KOREA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 50Â Â Â Â Â Â AUSTRALIA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 51Â Â Â Â Â Â AUSTRALIA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 52Â Â Â Â Â Â AUSTRALIA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 53Â Â Â Â Â Â SOUTH-EAST ASIA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 54Â Â Â Â Â Â SOUTH-EAST ASIA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 55Â Â Â Â Â Â SOUTH-EAST ASIA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 56Â Â Â Â Â Â REST OF ASIA PACIFIC DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 57Â Â Â Â Â Â REST OF ASIA PACIFIC DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 58Â Â Â Â Â Â REST OF ASIA PACIFIC DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 59Â Â Â Â Â Â EUROPE DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 60Â Â Â Â Â Â EUROPE DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 61Â Â Â Â Â Â EUROPE DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 62Â Â Â Â Â Â EUROPE DRUG DISCOVERY SERVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 63Â Â Â Â Â Â GERMANY DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 64Â Â Â Â Â Â GERMANY DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 65Â Â Â Â Â Â GERMANY DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 66Â Â Â Â Â Â UK DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 67Â Â Â Â Â Â UK DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 68Â Â Â Â Â Â UK DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 69Â Â Â Â Â Â FRANCE DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 70Â Â Â Â Â Â FRANCE DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 71Â Â Â Â Â Â FRANCE DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 72Â Â Â Â Â Â ITALY DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 73Â Â Â Â Â Â ITALY DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 74Â Â Â Â Â Â ITALY DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 75Â Â Â Â Â Â SPAIN DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 76Â Â Â Â Â Â SPAIN DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 77Â Â Â Â Â Â SPAIN DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 78Â Â Â Â Â Â RUSSIA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 79Â Â Â Â Â Â RUSSIA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 80Â Â Â Â Â Â RUSSIA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 81Â Â Â Â Â Â REST OF EUROPE DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 82Â Â Â Â Â Â REST OF EUROPE DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 83Â Â Â Â Â Â REST OF EUROPE DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 84Â Â Â Â Â Â MIDDLE EAST AND AFRICA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 85Â Â Â Â Â Â MIDDLE EAST AND AFRICA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 86Â Â Â Â Â Â MIDDLE EAST AND AFRICA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 87Â Â Â Â Â Â MIDDLE EAST AND AFRICA DRUG DISCOVERY SERVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 88Â Â Â Â Â Â UAE DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 89Â Â Â Â Â Â UAE DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 90Â Â Â Â Â Â UAE DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 91Â Â Â Â Â Â SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 92Â Â Â Â Â Â SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 93Â Â Â Â Â Â SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 94Â Â Â Â Â Â SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 95Â Â Â Â Â Â SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 96Â Â Â Â Â Â SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 97Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA DRUG DISCOVERY SERVICES MARKET BY PROCESS (USD BILLION) 2020-2029
TABLE 98Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE (USD BILLION) 2020-2029
TABLE 99Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
Â
LIST OF FIGURES
FIGURE 1Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY PROCESS, USD BILLION, 2020-2029
FIGURE 9Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE, USD BILLION, 2020-2029
FIGURE 10Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA, USD BILLION, 2020-2029
FIGURE 11Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY REGION, USD BILLION, 2020-2029
FIGURE 12   PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY PROCESS, USD BILLION, 2021
FIGURE 14Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY DRUG TYPE, USD BILLION, 2021
FIGURE 15Â Â Â GLOBAL DRUG DISCOVERY SERVICES MARKET BY THERAPEUTIC AREA, USD BILLION, 2021
FIGURE 16   GLOBAL DRUG DISCOVERY SERVICES MARKET BY REGION, USD BILLION, 2021
FIGURE 17Â Â Â MARKET SHARE ANALYSIS
FIGURE 18Â Â Â EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
FIGURE 19Â Â Â EVOTEC SE: COMPANY SNAPSHOT
FIGURE 20Â Â Â WUXI APPTEC: COMPANY SNAPSHOT
FIGURE 21Â Â Â SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT
FIGURE 22Â Â Â CURIA GLOBAL INC.: COMPANY SNAPSHOT
FIGURE 23Â Â Â PHARMARON BEIJING CO., LTD.: COMPANY SNAPSHOT
FIGURE 24Â Â Â PIRAMAL ENTERPRISES LIMITED: COMPANY SNAPSHOT
FIGURE 25Â Â Â THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 26Â Â Â JUBILANT PHARMOVA LIMITED: COMPANY SNAPSHOT
FIGURE 27Â Â Â GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT
FIGURE 28Â Â Â ONCODESIGN SERVICES: COMPANY SNAPSHOT
FIGURE 29Â Â Â SELVITA S.A.: COMPANY SNAPSHOT
FAQ
the global drug discovery services market was valued at 17.92 billion in 2022 and is projected to reach 47.38 billion by 2029, growing at a CAGR of 14.9% from 2022 to 2029
based on process, drug type, therapeutic area, and region the drug discovery services market reports divisions are broken down.
the global drug discovery services market registered a CAGR of 14.9% from 2022 to 2029. the industry segment was the highest revenue contributor to the market.
In 2020, the drug discovery services market in North America was the largest. The various CROs and CMOs in the area support the presence of several leading biopharmaceutical and pharmaceutical businesses, which promotes the expansion of the market for drug development services. Most newly produced medications have patents held by the US.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.